Angiopoietin-2 Confers Atheroprotection in apoE−/− Mice by Inhibiting LDL Oxidation via Nitric Oxide

A Ahmed, T Fujisawa, XL Niu, S Ahmad… - Circulation …, 2009 - Am Heart Assoc
A Ahmed, T Fujisawa, XL Niu, S Ahmad, B Al-Ani, K Chudasama, A Abbas, R Potluri
Circulation research, 2009Am Heart Assoc
Atherosclerosis is promoted by a combination of hypercholesterolemia and vascular
inflammation. The function of Angiopoietin (Ang)-2, a key regulator of angiogenesis, in the
maintenance of large vessels is unknown. A single systemic administration of Ang-2
adenovirus (AdAng-2) to apoE−/− mice fed a Western diet significantly reduced
atherosclerotic lesion size (≈ 40%) and oxidized LDL and macrophage content of the
plaques. These beneficial effects were abolished by the inhibition of nitric oxide synthase …
Atherosclerosis is promoted by a combination of hypercholesterolemia and vascular inflammation. The function of Angiopoietin (Ang)-2, a key regulator of angiogenesis, in the maintenance of large vessels is unknown. A single systemic administration of Ang-2 adenovirus (AdAng-2) to apoE−/− mice fed a Western diet significantly reduced atherosclerotic lesion size (≈40%) and oxidized LDL and macrophage content of the plaques. These beneficial effects were abolished by the inhibition of nitric oxide synthase (NOS). In endothelial cells, endothelial NOS activation per se inhibited LDL oxidation and Ang-2 stimulated NO release in a Tie2-dependent manner to decrease LDL oxidation. These findings demonstrate a novel atheroprotective role for Ang-2 when endothelial cell function is compromised and suggest that growth factors, which stimulate NO release without inducing inflammation, could offer atheroprotection.
Am Heart Assoc